Bruton’s tyrosine kinase (BTK) inhibitors in treating cancer: a patent review (2010-2018)Yifan Feng, Minhang Xin, Chengyuan Liang et al.|Expert Opinion on Therapeutic Patents|2019Cited by 59
Discovery of 2,4,6-trisubstitued pyrido[3,4-d]pyrimidine derivatives as new EGFR-TKIsHao Zhang, San‐Qi Zhang, Hongyi Zhao et al.|European Journal of Medicinal Chemistry|2018Cited by 49
Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitorsMinhang Xin, San‐Qi Zhang, Yifan Feng et al.|Bioorganic & Medicinal Chemistry|2018Cited by 28